Drugs / IPH5301
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05143970 | Jan 2022 → Mar 2027 expected | breast cancer, endometrial cancer, esophageal cancer, gastric cancer +4 | Institut Paoli-Calmettes | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPH5301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05143970 ↗ |